Google Alert - Business

	Business Daily update ⋅ February 4, 2023
	NEWS
	NPR Manufacturer recalls eye drops after possible link to bacterial infections NPR The CDC said an outbreak of this particular strain of Pseudomonas aeruginosa, VIM-GES-CRPA, has not been detected in the U.S. before. Opened bottles of EzriCare artificial tears ... Flag as irrelevant
	Norton Rose Fulbright Policies for Improving Sovereign Debt Restructurings Federal Reserve Bank of Richmond Recent sovereign default restructurings during the COVID-19 pandemic have reignited interest in research and policy suggestions for improving these restructuring episodes. Evidence for the effectiveness of these policies has largely come from empirical ... Flag as irrelevant
	Brunswick Group The Future of Remedies in Global Merger Control Brunswick Group On January 25, Brunswick hosted a panel discussion to deliberate the future of merger remedies and how business can best navigate a more challenging global regulatory environment for dealmaking. Panelists were Nicole Kar, global head of antitrust ... Flag as irrelevant
	Elite Business Magazine Data Protection update – December 2022-January 2023 Stephenson Harwood Cyber security · Investigations launched into Twitter following data breaches · Royal Mail unable to send post overseas following Russia-linked ransomware attack · TSB Bank fined £48.6 million following 2018 IT crash · Passwords stored in Norton Password ... Flag as irrelevant
	United States Steel Corp - Overview US Steel Delivering on Strategic Commitments; Reports Solid Fourth Quarter and Second-Best Earnings in 2022 United States Steel Corp - Overview PITTSBURGH--(BUSINESS WIRE)-- United States Steel Corporation (NYSE: X) reported fourth quarter 2022 net earnings of $174 million, or $0.68 per diluted share. Adjusted net earnings was $226 million, or $0.87 ... Flag as irrelevant
	Medtech Insight A new role for EMA in monitoring and mitigating critical medical device shortages during public health emergencies European Medicines Agency | The Agency is now responsible for coordinating responses of EU / EEA countries to shortages of critical medicines and medical devices including in-vitro diagnostics during public health emergencies. The Medical Devices Shortages Steering Group (MDSSG) ... Flag as irrelevant
	Hindustan Times Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III ... ASCO Journals Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. We report 5-year efficacy and safety outcomes ... Flag as irrelevant
	Hindustan Times Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS ... Merck February 3, 2023 6:45 am ET. KEYTRUDA plus chemotherapy significantly improved PFS versus standard of care chemotherapy alone as first-line treatment for patients with stage III-IV or recurrent endometrial carcinoma regardless of mismatch repair status. Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback